Davide Leone & Partners Investment Company’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-29,395	Closed	-$2.01M	–	139
2021 Q1	$2.01M	Buy	29,395 +10,387	+55%	+$840K	0.25%	51
2020 Q4	$1.63M	Buy	+19,008	New	+$1.61M	0.17%	66

Other funds holding BHVN

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Davide Leone & Partners Investment Company's BHVN Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2021, closing a stake of 29,395 shares — an estimated $2.01M sold.

Davide Leone & Partners Investment Company first reported a position in BHVN in Q4 2020 and held it in 2 quarters. The position peaked at $2.01M in Q1 2021. 223 funds tracked by Wall St. Rank hold BHVN as of Q2 2021.

Davide Leone & Partners Investment Company reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2021 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 29,395 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2021, an estimated $2.01M.
Davide Leone & Partners Investment Company first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q4 2020 and held it in 2 quarters.
Davide Leone & Partners Investment Company's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $2.01M in Q1 2021.
223 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.